Medtronic Endurant(TM) II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX(TM) EndoAnchor(TM) System
Go back to Medtronic Endurant(TM) II/IIs Stent Graft System Receives FDA Approval to Treat Short Neck Anatomies When Used with Heli-FX(TM) EndoAnchor(TM) System| Medtronic Inc. (NYSE: MDT) | Delayed: 79.24 +0.05 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.19 | 52 Week High | $89.27 | |||
| Open | $79.53 | 52 Week Low | $71.03 | |||
| Day High | $79.64 | P/E | 22.51 | |||
| Day Low | $79.24 | EPS | $3.52 | |||
| Volume | 1,994,979 | |||||
